1081P DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients
Marco Filetti(Agostino Gemelli University Polyclinic), Luca Farina(Sapienza University of Rome), Raffaele Giusti(CTO Andrea Alesini), Mario Occhipinti(Fondazione IRCCS Istituto Nazionale dei Tumori), Andrea Botticelli(Policlinico Umberto I), Manuela Petti(Sapienza University of Rome), Elisabetta Ferretti(Sapienza University of Rome), Pasquale Lombardi(Università Cattolica del Sacro Cuore), Fabio Scirocchi(Bambino Gesù Children's Hospital), Albenzio Cirillo(Sapienza University of Rome), Aurelia Rughetti(Sapienza University of Rome), Giuseppe Lo Russo(Fondazione IRCCS Istituto Nazionale dei Tumori), M. Núti(Sapienza University of Rome), Piero Marchetti(University of Pisa), Alessio Ugolini(The Wistar Institute), Filippo de Braud(University of Milan)
Cited by 0
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
|The Lancet Oncology|2019|537
Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
|American Journal of Transplantation|2014|522